Glycoside apoptosis inducer/alpha-fetoprotein complex

N/A

Report date: 2022/03/14 17:17:11

Base Information

Drug NameGlycoside apoptosis inducer/alpha-fetoprotein complex
Drug Alias NameAimpila
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionApoptosis stimulantsAlpha-fetoprotein inhibitors
TargetsAlpha-fetoprotein
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesConstab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConstab
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A